Nowa wersja platformy, zawierająca wyłącznie zasoby pełnotekstowe, jest już dostępna.
Przejdź na


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2008 | 3 | 3 | 332-340
Tytuł artykułu

No association between vulvovaginitis-bacterial vaginosis, related drug treatments of pregnant women, and congenital abnormalities in their offspring - A population-based case-control study

Treść / Zawartość
Warianty tytułu
Języki publikacji
The possible association between prospectively and medically recorded vulvovaginitis-bacterial vaginosis (VV-BV) and different congenital abnormalities (CA) has not been studied. The data set of the population-based Hungarian Case-Control Surveillance of Congenital Abnormalities between 1980 and 1996 were evaluated, i.e. 22,843 pregnant women who had newborns or fetuses with congenital abnormality (cases) and 38,151 pregnant women who delivered newborn babies without any congenital abnormality (controls). The main outcome measures were different congenital abnormalities. Of 22,843 cases with CA, 1,536 (6.7%) had mothers with VV-BV, while of 38,151 matched controls without CA, 2,698 (7.1%) had mothers with VV-BV in the second and/or third gestational month of pregnancy. Nearly all pregnant women with VV-BV were treated during pregnancy, but a higher risk for the total group of CAs (adjusted POR with 95% CI: 0.95, 0.89–1.02) or any CA group was not found. In addition, the risk for total CAs was significantly lower in cases born to mothers with VV-BV and appropriate treatment than born to mothers with VV-BV but without treatment. Thus maternal VV-BV needs treatment during pregnancy as well, because it helps reduce the rate of preterm birth without a risk for CAs.

Opis fizyczny
  • Second Department of Obstetrics and Gynecology, Semmelweis University, School of Medicine, Budapest, Hungary
  • Second Department of Obstetrics and Gynecology, Semmelweis University, School of Medicine, Budapest, Hungary
  • Foundation for the Community Control of Hereditary Diseases, Budapest, Hungary
  • [1] Czeizel A.E., Ács N., Bánhidy F., Vogt G., Possible association between maternal diseases and congenital abnormalities. In: Engels J.V. (ed.): Birth Defects New Research, NOVA Scientific Publ. New York, 2006. pp. 55–70.
  • [2] Murphy V., Kennea N.L., Antenatal infection/inflammation and fetal tissue injury. Best Pract. Res. Clin. Obstet. Gynaecol., 2007, 21, 479–489[Crossref]
  • [3] Divers M.J., Lilford R.J., Infection and preterm labour: a meta-analysis. Contemp. Rev. Obstet. Gynecol., 1993, 5, 71–84
  • [4] Chin B.M., Lamon R.F., The microbiology of preterm labour and delivery. Contemp. Rev. Obstet. Gynecol., 97, 9, 285–296
  • [5] Czeizel A.E., Puhó E., Kazy Z., The use of data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities for the evaluation of birth outcomes beyond congenital abnormalities. Centr. Eur. J. Publ. Hlth., 2007, 15, 147–153.
  • [6] Brown Z.A., Vontrer L.A., Benedetti J., et al., Effects on infants of a first episode of genital herpes during pregnancy. N. Engl. J. Med., 1987, 317,1246–50
  • [7] Baldwin S., Whitley R.J., Intrauterine herpes simplex virus infection. Teratology, 1989, 39,1–10[Crossref]
  • [8] Ingall D., Norris L., Syphilis., Infectious Diseases of the Fetus and Newborn Infant. Chapter 9. In: Demington J.S., Klein J.O. (eds.). Saunders Col, Philadelphia, 1976, 414–463
  • [9] Grossman J., Congenital syphilis. Teratology, 1977, 16, 217–224[Crossref]
  • [10] Shepard T.H., Lemire R.J., Catalog of Teratogenic Agents, 11th ed. Johns Hopkins Univ. Pres. Baltimore, 2004
  • [11] Pursley T.J., Blomquist I.K., Abraham J. et al., Fluconazole-induced congenital anomalies in three infants. Clin. Infect. Dis., 1995, 22, 336–340
  • [12] Aleck X.A., Bartley D.L., Multiple malformation syndrome following fluconazole use in pregnancy. Am. J. Med. Genet., 1997, 72, 253–256<253::AID-AJMG1>3.0.CO;2-S[Crossref]
  • [13] Czeizel A.E., Rockenbauer M., Siffel Cs., Varga E., Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980–1996. Teratology, 2001, 63,176–185[Crossref]
  • [14] Czeizel A.E., First 25 years of the Hungarian Congenital Abnormality Registry. Teratology, 1997, 55, 299–305<299::AID-TERA1>3.0.CO;2-V[Crossref]
  • [15] Czeizel A.E., Intődy Zs., Modell B., What proportion of congenital abnormalities can be prevented? Brit. Med. J., 1993, 306, 499–503[Crossref]
  • [16] Czeizel A.E., Petik D., Vargha P., Validation studies of drug exposures in pregnant women. Pharmacoepid. Drug Safety, 2003, 12, 409–416[Crossref]
  • [17] Yarberry-Allen P., Ledger W.J., Milstein S.J., Infections of the female genital tract. In: Roberts R.B., (ed). Infectious Diseases: Pathogenesis, Diagnosis and Therapy. Year Book Medical Publ. Chicago, 1986
  • [18] Amsell R., Totten P.A., Spiegel C.A. et al., Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiological associations. Am. J. Med., 1983, 74,14–22[Crossref]
  • [19] Sonnex C., The amine test: a simple, rapid, inexpensive method for diagnosing bacterial vaginosis. Br. J. Obstet. Gynecol., 1995, 102,160–161
  • [20] Nugent R.P., Krohn M.A., Hillier S.L., Reliability of diagnosing bacterial vaginosis is improved by a standard method of Gram stain interpretation. J. Clin. Microbiol., 1991, 29, 297–301
  • [21] Donders G.G.G., Definition and classification of abnormal vaginal flora. Best Pract. Res. Clin. Obstet. Gynecol., 2007, 21, 355–373[Crossref]
  • [22] Donders G.G.G., Vereecken A., Bosmanic E., et al., Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. Br. J. Obstet. Gynecol., 2002, 109, 1–10
  • [23] Cibley L.J., Cytolytic vaginosis. Am. J. Obstet. Gynecol., 1991, 165, 1245–1249
  • [24] Czeizel A.E., Ten years’ experience in periconception care. Eur. J. Obstet. Gynecol. Reprod. Biol., 1999, 84, 43–49[Crossref]
  • [25] Bánhidy F., Ács N., Puhó E., Czeizel A.E., Pregnancy complications and birth outcomes of pregnant women with urinary tract infections and related drug treatments. Scan. J. Inf. Dis., 2007, 39, 390–397[Crossref][WoS]
  • [26] Pazonyi I., Kun A., Czeizel A.E., Congenital postural deformity association. Acta Paediatr. Acad. Sci. Hung., 1982, 23, 431–445
  • [27] Czeizel A.E., Rockenbauer M., A population-based case-control teratologic study of oral metronidazole treatment during pregnancy. Br. J. Obstet. Gynecol., 1998, 105, 322–327
  • [28] Czeizel A.E., Fladung B., Vargha P., Preterm birth reduction after clotrimazole treatment during pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol., 2004, 16,157–163[Crossref]
  • [29] Czeizel A.E., Rockenbauer M., Sorensen H.T., Olsen J., A population-based case-control teratologic study of ampicillin treatment during pregnancy. Am. J. Obstet. Gynecol., 2001, 185, 140–147[Crossref]
  • [30] Czeizel A.E., Rockenbauer M., Sorensen H.T., Olsen J., A population-based case-control teratologic study of penicillin V: oral penamecillin treatment during pregnancy. Con. Anom., (Kyoto) 1999, 39, 267–279[Crossref]
  • [31] Czeizel A.E., Rockenbauer M., Soprensen H.T., Olsen J., Nitrofurantoin and congenital abnormalities. Eur. J. Obstet. Gynecol. Reprod. Biol., 2001, 95, 119–126[Crossref]
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.